» Articles » PMID: 17588340

Small Interfering RNA of Cyclooxygenase-2 Induces Growth Inhibition and Apoptosis Independently of Bcl-2 in Human Myeloma RPMI8226 Cells

Overview
Specialty Pharmacology
Date 2007 Jun 26
PMID 17588340
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To investigate the effects of small interfering RNA of cyclooxygenase-2 (COX-2) on the proliferation and apoptosis of human multiple myeloma RPMI8226 cells and its relation with the Bcl-2 family in vitro.

Methods: Transcription and expression of COX-2 in human myeloma RPMI8226 cells were checked by RT-PCR and Western blot analysis, respectively. The COX-2 siRNA fragment targeting exon 5 of COX-2 gene was transfected into the cells with the Amaxa nucleofection technique. The inhibition of cell growth was detected by 3-(4,5-dimethyl-2- thiazolyl)-2,5-diphenyl-2H-tetrazolium (MTT) assay. Apoptosis was estimated by Annexin-V/ propidium iodide double-labeled cytometry and confirmed by terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling assay. Bcl-2 and Bax expression was evaluated by Western blot analysis.

Results: The COX-2 siRNA fragment could be successfully transfected into RPMI8226 cells, which resulted in the significant inhibition of transcription and expression of COX-2 in the myeloma cells. Proliferation of the transfected cells was inhibited and apoptosis was induced (6.52%+/-0.32%, 12.53%+/-2.52%, 24.39%+/-3.51% and 36.48%+/-4.96% for 0, 12, 24, and 48 h, respectively) in a time-dependent manner (P<0.01). However, the expression of Bcl-2 and Bax in the RPMI8226 cells had no significant changes after nucleofection.

Conclusion: COX-2 siRNA transfection can suppress COX-2 expression in human myeloma RPMI8226 cells, which leads to growth inhibition and apoptosis independent of Bcl-2.

Citing Articles

COX2 confers bone marrow stromal cells to promoting TNFα/TNFR1β-mediated myeloma cell growth and adhesion.

Kuang C, Zhu Y, Guan Y, Xia J, Ouyang J, Liu G Cell Oncol (Dordr). 2021; 44(3):643-659.

PMID: 33646559 DOI: 10.1007/s13402-021-00590-4.


Thromboxane A2 Receptor Inhibition Suppresses Multiple Myeloma Cell Proliferation by Inducing p38/c-Jun N-terminal Kinase (JNK) Mitogen-activated Protein Kinase (MAPK)-mediated G2/M Progression Delay and Cell Apoptosis.

Liu Q, Tao B, Liu G, Chen G, Zhu Q, Yu Y J Biol Chem. 2016; 291(9):4779-92.

PMID: 26724804 PMC: 4813499. DOI: 10.1074/jbc.M115.683052.


Cancer/Testis Antigen MAGE-C1/CT7: new target for multiple myeloma therapy.

de Carvalho F, Vettore A, Colleoni G Clin Dev Immunol. 2012; 2012:257695.

PMID: 22481966 PMC: 3310219. DOI: 10.1155/2012/257695.


shRNA-targeted cyclooxygenase (COX)-2 inhibits proliferation, reduces invasion and enhances chemosensitivity in laryngeal carcinoma cells.

Wang R, Wang X, Lin F, Gao P, Dong K, Zhang H Mol Cell Biochem. 2008; 317(1-2):179-88.

PMID: 18592138 DOI: 10.1007/s11010-008-9847-9.